Repositorio Dspace

Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets

Mostrar el registro sencillo del ítem

dc.contributor.author Nanda, Sambit-K
dc.contributor.author Vollmer, Stefan
dc.contributor.author Pérez-Oliva, Ana-B
dc.date.accessioned 2025-11-21T08:48:43Z
dc.date.available 2025-11-21T08:48:43Z
dc.date.issued 2022
dc.identifier.citation Nanda SK, Vollmer S, Perez-Oliva AB. Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets. Front Cell Dev Biol. 21 de junio de 2022;10:887533.
dc.identifier.issn 2296-634X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22050
dc.description.abstract In this review, we have summarized classical post-translational modifications (PTMs) such as phosphorylation, ubiquitylation, and SUMOylation of the different components of one of the most studied NLRP3, and other emerging inflammasomes. We will highlight how the discovery of these modifications have provided mechanistic insight into the biology, function, and regulation of these multiprotein complexes not only in the context of the innate immune system but also in adaptive immunity, hematopoiesis, bone marrow transplantation, as well and their role in human diseases. We have also collected available information concerning less-studied modifications such as acetylation, ADP-ribosylation, nitrosylation, prenylation, citrullination, and emphasized their relevance in the regulation of inflammasome complex formation. We have described disease-associated mutations affecting PTMs of inflammasome components. Finally, we have discussed how a deeper understanding of different PTMs can help the development of biomarkers and identification of novel drug targets to treat diseases caused by the malfunctioning of inflammasomes.
dc.language.iso eng
dc.publisher Frontiers Media S.A.
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.title Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35800898
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fcell.2022.887533/full
dc.identifier.doi 10.3389/fcell.2022.887533
dc.journal.title Frontiers in Cell and Developmental Biology


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta